All News

Gossamer Bio Appoints Bryan Giraudo as COO, in addition to CFO Role
Ref: Business Wire
Tags: People NewsGossamer Bio Corporate Affairs
Fusion Pharmaceuticals Appoints Eric Hoffman as SVP, Business Development
Ref: PR Newswire
Tags: People NewsAstraZeneca Biogen Fusion Pharmaceuticals Genocea Idenix Merck & Co. Corporate Affairs
Galectin Therapeutics Announces $20 Million Convertible Debt Financing from Its Chairman, Richard E. Uihlein
Ref: GlobeNewswire
Tags: Press ReleaseGalectin Therapeutics Corporate Affairs
Booster dose of J&J's COVID-19 vaccine shows 94% effectiveness
Ref: CNBC, The Wall Street Journal, ABC News, U.S. News &, World Report, CNN, Investing.com, PR Newswire, TheStreet
Tags: Top StoryJ&JCOVID-19 Immunisation Clinical Research (R&D)
Neuren submits IND application for NNZ-2591 in Phelan-McDermid syndrome
Ref: Neuren Pharmaceuticals
Tags: Press ReleaseNeuren Pharmaceuticals FDAClinical Research (R&D) Regulatory AffairsNNZ-2591
Seneca Therapeutics, Inc. Announces Launch of a Novel Cancer Gene Delivery Platform based on SVV-001 Technology
Ref: Business Wire
Tags: Press ReleaseSeneca Therapeutics Clinical Research (R&D)SVV-001
Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the Development of Oncoral in Combination with LONSURF
Ref: Ascelia Pharma
Tags: Press ReleaseAscelia Pharma TaihoGastric Cancer Corporate AffairsLonsurf Oncoral
Hyloris Announces Further Extension of Maxigesic IV Footprint
Ref: GlobeNewswire
Tags: Press ReleaseAFT Pharmaceuticals Hyloris Kyongbo Pharm Pharma BavariaPain Management Marketing & Sales Regulatory AffairsMaxigesic
HUTCHMED Initiates SURTORI-01, a Phase III Trial of SULANDA in Combination with TUOYI in the Treatment of Advanced Neuroendocrine Carcinoma in China
Ref: GlobeNewswire
Tags: Press ReleaseHUTCHMED Junshi Biosciences Clinical Research (R&D)Sulanda Tuoyi
Cryo-Cell Announces Changes To Its Board of Directors
Ref: GlobeNewswire
Tags: People NewsCryo-Cell Corporate Affairs